Correlation Between Sinphar Pharmaceutical and Medigen Biotechnology
Can any of the company-specific risk be diversified away by investing in both Sinphar Pharmaceutical and Medigen Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sinphar Pharmaceutical and Medigen Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sinphar Pharmaceutical Co and Medigen Biotechnology, you can compare the effects of market volatilities on Sinphar Pharmaceutical and Medigen Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sinphar Pharmaceutical with a short position of Medigen Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sinphar Pharmaceutical and Medigen Biotechnology.
Diversification Opportunities for Sinphar Pharmaceutical and Medigen Biotechnology
0.73 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Sinphar and Medigen is 0.73. Overlapping area represents the amount of risk that can be diversified away by holding Sinphar Pharmaceutical Co and Medigen Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Medigen Biotechnology and Sinphar Pharmaceutical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sinphar Pharmaceutical Co are associated (or correlated) with Medigen Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Medigen Biotechnology has no effect on the direction of Sinphar Pharmaceutical i.e., Sinphar Pharmaceutical and Medigen Biotechnology go up and down completely randomly.
Pair Corralation between Sinphar Pharmaceutical and Medigen Biotechnology
Assuming the 90 days trading horizon Sinphar Pharmaceutical Co is expected to generate 0.3 times more return on investment than Medigen Biotechnology. However, Sinphar Pharmaceutical Co is 3.32 times less risky than Medigen Biotechnology. It trades about 0.15 of its potential returns per unit of risk. Medigen Biotechnology is currently generating about 0.02 per unit of risk. If you would invest 3,090 in Sinphar Pharmaceutical Co on November 28, 2024 and sell it today you would earn a total of 60.00 from holding Sinphar Pharmaceutical Co or generate 1.94% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 94.44% |
| Values | Daily Returns |
Sinphar Pharmaceutical Co vs. Medigen Biotechnology
Performance |
| Timeline |
| Sinphar Pharmaceutical |
| Medigen Biotechnology |
Sinphar Pharmaceutical and Medigen Biotechnology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Sinphar Pharmaceutical and Medigen Biotechnology
The main advantage of trading using opposite Sinphar Pharmaceutical and Medigen Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sinphar Pharmaceutical position performs unexpectedly, Medigen Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Medigen Biotechnology will offset losses from the drop in Medigen Biotechnology's long position.| Sinphar Pharmaceutical vs. Abnova Taiwan Corp | Sinphar Pharmaceutical vs. YungShin Global Holding | Sinphar Pharmaceutical vs. Phytohealth Corp | Sinphar Pharmaceutical vs. Wellell |
| Medigen Biotechnology vs. Orient Semiconductor Electronics | Medigen Biotechnology vs. Bright Led Electronics | Medigen Biotechnology vs. Taiwan Chinsan Electronic | Medigen Biotechnology vs. First Hotel Co |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Other Complementary Tools
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |